Navigation Links
The aorta is torn apart in the Marfan syndrome

A severe complication of the Marfan syndrome is that the aorta may split and be torn apart. The patient can be protected if the syndrome is diagnosed and treated in good time. In the current edition of the Deutsches rzteblatt International (Dtsch Arztebl Int 2008; 105[27]: 483-91), the human geneticist Mine Arslan-Kirchner from Hannover University Medical School and his coauthors present additional studies on Marfan patients.

Marfan syndrome occurs at a frequency of between 1:5000 and 1:10000 and is either hereditary or the result of spontaneous genetic mutations. As a consequence, there are changes in the consistency of connective tissue. Symptoms develop in the cardiovascular system, the eyes, and the skeleton. A much feared and potentially fatal complication is that the aorta can split and tear. The patient can then die from internal bleeding. Patients' average life expectancy is 32 years without treatment, but can be extended to 60 years with optimal therapy. The full-blown disease is not always present; individual symptoms may be lacking. This makes reliable diagnosis difficult and in many cases, clinical and molecular genetic studies must be combined to clarify the situation. If the diagnosis is made in good time, the damaged aorta can be surgically replaced.


Contact: Elke Bartholomaeus
Deutsches Aerzteblatt International

Page: 1

Related biology news :

1. After more than 100 years apart, webworms devastate New Zealand parsnips
2. Gene regulation, not just genes, is what sets humans apart
3. Researchers discover gene for branchio-oculo-facial syndrome
4. Study suggests new way to screen infants for fetal alcohol syndrome
5. Effective ADHD treatment found for children with fragile X syndrome
6. Rare cancer-causing syndrome found, for the first time, in Singapore
7. Obesity-related hormone is higher in children with Down syndrome
8. Restless legs syndrome affects nearly 2 percent of US/UK children
9. Researchers identify proteins involved in new neurodegenerative syndrome
10. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
Post Your Comments:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
(Date:10/29/2015)... 2015 Today, LifeBEAM , a ... 2XU, a global leader in technical performance sports ... with advanced bio-sensing technology. The hat will allow ... key biometrics to improve overall training performance. As ... will bring together the most advanced technology, extensive ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , ... November 30, 2015 , ... Global Stem Cells Group announced the ... in the cities of Arica and Iquique in northern Chile. The facilities are part of ... the most advanced protocols and techniques in stem cell medicine to patients from around the ...
(Date:11/30/2015)... Mass. , Nov. 30, 2015 ... HART ), a biotechnology company developing bioengineered organ ... received written notification from The NASDAQ Stock Market ... bid price requirements. The letter noted that as ... HART,s common stock having exceeded $1.00 per share ...
(Date:11/30/2015)... Nov. 30, 2015 Human Longevity, Inc. (HLI), ... has acquired Cypher Genomics, Inc., a leading genome informatics ... interpretation software solutions. The San Diego ... including Cypher CEO and Co-founder, Ashley Van Zeeland , ... Business.  Financial details of the deal were not disclosed. ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December 1-4, ... in Vienna, Austria to be ... owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), announced ... Therapy Suite at the 3rd European Congress of NeuroRehabilitation ...
Breaking Biology Technology: